Clee Medical develops intraoperative imaging and navigation technologies designed to enable more precise and minimally invasive brain surgery. The company’s platform combines high-resolution imaging with software tools that support real-time guidance during neurosurgical procedures. Its systems are intended to enhance visualization of brain structures beyond what is available with conventional intraoperative tools. Clee Medical positions its technology within regulated surgical and hospital environments.

The technology integrates ultra-high-resolution imaging with AI-driven navigation to assist surgeons in identifying anatomical boundaries and critical structures during procedures. By processing imaging data in real time, the system supports continuous orientation and adjustment as surgery progresses. This approach is designed to reduce reliance on preoperative images alone and to account for intraoperative brain shift. The platform emphasizes accuracy, spatial awareness, and seamless integration into surgical workflows.

Clee Medical targets applications in neurosurgery where precision and tissue preservation are critical, including tumor resection and other complex brain procedures. The technology is intended for use by specialized surgical teams within established clinical pathways. Its positioning reflects broader efforts to combine advanced imaging and AI to improve surgical outcomes while minimizing invasiveness.